Company profile
Home Page - Aptamer Group
Rapid Optimer development as antibody alternatives for therapeutic, drug delivery, diagnostics and bioprocessing.
Updated 06 Jun 2026 16:52
Financial period: 1 Jul 2024 to 30 Jun 2025
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
1 Jul 2013 to 31 May 2014
This project brings together the innovative detection technology of Paraytec Ltd with the target recognition technology provided by Aptamer Diagnostic Ltd to create the next generation of detection instruments. These novel platforms will allow rapid field and point-of-care based diagnosis based on multiple markers of disease or contamination. Simultaneous...
